OpenVSafe by OpenVAERS
Search V-safe

CNZ-12941-72160

3 vaccinations 13 coded responses 26 check-ins 13 free-text entries 4 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
523 / IA
Registered
2021-03-18
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-16
    Dose 1 — Moderna
  2. 2021-03-18
    Registered in v-safe
  3. 2021-03-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  4. 2021-03-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  5. 2021-03-21
    Survey response — days 1–6 daily, dose 1
    MedDRA: Decreased appetite, Neck pain — Feeling: Poor · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities
    Free text: Sore neck; low appetite
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-03-22
    Survey response — days 1–6 daily, dose 1
    MedDRA: Lymphadenopathy — Feeling: Fair · Muscle or body aches, Fatigue or tiredness, Nausea
    Free text: Swollen lymph nodes
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-03-23
    Survey response — day 7, dose 1
    MedDRA: Anxiety, Dysphoria — Feeling: Poor · Site: Pain, Redness, Swelling · Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Feeling dysphoric and anxious
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-03-30
    Survey response — day 14, dose 1
    MedDRA: Anxiety, Inflammation, Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling, Insomnia, Urticaria — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Injection site continued to swell, redden, be painful, and then itch, before symptoms subsided. Welt was about 7 inches in diameter at its maximum. Severe Anxiety and insomnia have also lessened in tandem as arm inflammation subsided.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-04-08
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-04-13
    Health check-in — day 28, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-04-15
    Dose 2 — Moderna
  12. 2021-04-15
    Health check-in — day 0, dose 2
    Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  13. 2021-04-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  14. 2021-04-17
    Survey response — days 1–6 daily, dose 2
    MedDRA: Decreased appetite, Taste disorder, Thirst — Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Free text: Loss of appetite, thirst, altered taste
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-04-19
    Survey response — days 1–6 daily, dose 2
    MedDRA: Decreased appetite, Epistaxis, Feeling cold — Feeling: Fair · Site: Pain, Itching · Fever · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Loss of appetite, nosebleeds, feeling cold
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-04-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  17. 2021-04-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection site
    Adult check-in
  18. 2021-04-22
    Health check-in — day 7, dose 2
    Feeling: Good · Site: Itching · None
    Adult check-in
  19. 2021-04-29
    Survey response — day 14, dose 2
    MedDRA: Headache — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Headaches
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-05-06
    Survey response — day 21, dose 2
    MedDRA: Cough, Throat irritation — Feeling: Good
    Free text: Scratchy throat and occasional dry cough have persisted since vaccination. No other symptoms.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-05-13
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-05-20
    Survey response — day 35, dose 2
    MedDRA: Dyspnoea, Fatigue, Pharyngeal disorder — Feeling: Fair
    Free text: Continued weird throat and breathing issue. Fatigue.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-07-15
    Survey response — 3 months, dose 2
    MedDRA: Dizziness, Dysstasia, Fatigue, Heart rate irregular — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: I have developed what seems to be POTS syndrome, with dizziness and fatigue following the shot, combined with irregular heart rates and inability to stand vertically for long. The symptoms began after second moderna dosage.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  24. 2021-07-15
    Report sent to call center — 3 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  25. 2021-07-23
  26. 2021-10-23
    Dose 3 — Pfizer-BioNTech
  27. 2021-10-29
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Diarrhea · Be unable to do your normal daily activities
    Adult check-in
  28. 2021-11-01
    Health check-in — day 7, dose 3
    Feeling: Poor · Fever · Chills, Headache, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  29. 2021-11-06
    Health check-in — day 14, dose 3
    Feeling: Fair
    Adult check-in
  30. 2022-01-23
    Survey response — 3 months, dose 3
    MedDRA: Asthenia, Condition aggravated, Pre-existing disease — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: I have had a relapse of postural orthostatic tachycardia syndrome, which was triggered initially by my first set of covid vaccines. The booster exacerbated symptoms. Please look into incidences of the mrna vaccines causing this debilitating syndrome
    MedDRA releases: 2024-11 · check-in free text available
  31. 2022-01-23
    Report sent to call center — 3 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  32. 2022-01-24
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact
  33. 2022-01-24
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact
  34. 2022-04-24
    Survey response — 6 months, dose 3
    MedDRA: Pre-existing disease — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Chronic fatigue after minor exertion
    MedDRA releases: 2024-11 · check-in free text available
  35. 2022-04-24
    Report sent to call center — 6 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  36. 2022-04-26
  37. 2022-10-25
    Survey response — 12 months, dose 3
    MedDRA: Exercise tolerance decreased, Fatigue, Nausea — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Continued intermittent nausea and fatigue that is severe. Intolerance of exercise or exertion.
    MedDRA releases: 2024-11 · check-in free text available
  38. 2022-10-25
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  39. 2022-10-26
    Call successful
    Participant prefers to complete VAERS report online
  40. 2022-10-26
    Call successful
    Participant prefers to complete VAERS report online

Vaccinations

DoseDateManufacturerCo-administered
12021-03-16Moderna
22021-04-15Moderna
32021-10-23Pfizer-BioNTech No

Call center

4 call center cases

4 successful

VAERS report filed, before or during a call: 2

See the call center timeline

Free text

Release 6 — days 1–6 daily, dose 1

2021-03-21

Systemic reaction (other): Sore neck; low appetite

2021-03-22

Systemic reaction (other): Swollen lymph nodes

Release 6 — day 7, dose 1

2021-03-23

Systemic reaction (other): Feeling dysphoric and anxious

Release 6 — day 14, dose 1

2021-03-30

Symptoms: Injection site continued to swell, redden, be painful, and then itch, before symptoms subsided. Welt was about 7 inches in diameter at its maximum. Severe Anxiety and insomnia have also lessened in tandem as arm inflammation subsided.

Release 7 — days 1–6 daily, dose 2

2021-04-17

Systemic reaction (other): Loss of appetite, thirst, altered taste

2021-04-19

Systemic reaction (other): Loss of appetite, nosebleeds, feeling cold

Release 8 — day 14, dose 2

2021-04-29

Symptoms: Headaches

Release 8 — day 21, dose 2

2021-05-06

Symptoms: Scratchy throat and occasional dry cough have persisted since vaccination. No other symptoms.

Release 8 — day 35, dose 2

2021-05-20

Symptoms: Continued weird throat and breathing issue. Fatigue.

Release 9 — 3 months, dose 2

2021-07-15

Symptoms: I have developed what seems to be POTS syndrome, with dizziness and fatigue following the shot, combined with irregular heart rates and inability to stand vertically for long. The symptoms began after second moderna dosage.

Release 11 — 3 months, dose 3

2022-01-23

Symptoms: I have had a relapse of postural orthostatic tachycardia syndrome, which was triggered initially by my first set of covid vaccines. The booster exacerbated symptoms. Please look into incidences of the mrna vaccines causing this debilitating syndrome cut off by CDC

Release 11 — 6 months, dose 3

2022-04-24

Symptoms: Chronic fatigue after minor exertion

Release 12 — 12 months, dose 3

2022-10-25

Symptoms: Continued intermittent nausea and fatigue that is severe. Intolerance of exercise or exertion.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAnxiety ✓ ✓ ✓
SDAsthenia · · ✓
SDCondition aggravated · · ✓
SDCough ✓ ✓ ✓
SDDizziness ✓ · ✓
SDDyspnoea ✓ ✓ ✓
SDDysstasia ✓ · ✓
SDExercise tolerance decreased · · ✓
SDFatigue ✓ ✓ ✓
SDHeadache ✓ ✓ ✓
SDHeart rate irregular ✓ · ✓
SDInflammation ✓ ✓ ✓
SDInjection site erythema ✓ ✓ ✓
SDInjection site pain ✓ ✓ ✓
SDInjection site pruritus ✓ ✓ ✓
SDInjection site swelling ✓ ✓ ✓
SDInsomnia ✓ ✓ ✓
SDNausea · · ✓
SDPharyngeal disorder ✓ ✓ ✓
SDPre-existing disease · · ✓
SDThroat irritation ✓ ✓ ✓
SDUrticaria ✓ ✓ ✓
SROAnxiety ✓ ✓ ✓
SRODecreased appetite ✓ ✓ ✓
SRODysphoria ✓ ✓ ✓
SROEpistaxis ✓ ✓ ✓
SROFeeling cold ✓ ✓ ✓
SROLymphadenopathy ✓ ✓ ✓
SRONeck pain ✓ ✓ ✓
SROTaste disorder ✓ ✓ ✓
SROThirst ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release